Related Experiment Video
Updated: Feb 11, 2026

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
Mycophenolate mofetil therapy in adult patients with recalcitrant atopic dermatitis
David Dias-Polak1, Reuven Bergman1,2, Emily Avitan-Hersh1,2
1a Department of Dermatology, Rambam Health Care Campus , Technion - Israel Institute of Technology , Haifa , Israel.
Background:
Patients with severe atopic dermatitis (AD) may require potent immunosuppressive therapy to control their disease. Mycophenolate mofetil (MMF) has been suggested as a safe and effective drug in these cases.
Objectives:
To investigate effectiveness and tolerability of oral MMF in adult patients with severe recalcitrant AD.
Methods:
During the years 2010-2017 oral MMF 2-3 g/day was administered to adult patients with severe recalcitrant AD who failed other major systemic drugs, or where other drugs, including cyclosporine (CSA), methotrexate, and azathioprine, were contraindicated.
Results:
Of 9 consecutive adult patients, 4 (44%) responded completely, 2 (22%) had partial response, and 3 (33%) did not respond at all. The MMF therapy was continued for 5-36 months (average 21 months) without major side effects.
Conclusions:
Oral MMF may be an effective drug in AD. Due to its good safety profile, it may be recommended as a first-line systemic therapy, or successive to CSA in the long term.
Related Concept Videos
Gene Therapy
Group Therapy
Adult Stem Cells
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Drug Therapy
Antianxiety Medications
Cognitive Therapy

